ESC-derived retinal pigmented epithelial cell transplants in patients: so far, so good
- PMID: 25517461
- DOI: 10.1016/j.stem.2014.10.008
ESC-derived retinal pigmented epithelial cell transplants in patients: so far, so good
Abstract
Many untreatable blinding diseases involve degeneration of retinal pigmented epithelial (RPE) cells, which has prompted exploration of the therapeutic potential of human-pluripotent-stem-cell-derived RPE. The first safety trials reported in The Lancet of embryonic-stem-cell-derived RPE cell transplants indicate no serious adverse outcomes and encourage further investigation.
Copyright © 2014 Elsevier Inc. All rights reserved.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources